Showing results (51-60 of 98) with videos related to
Sort By:
Pageof 10
British Journal of Cancer|August 1, 1982
Small-cell lung cancer: initial treatment with sequential hemi-body irradiation VS 3-drug systemic chemotherapyR C Urtasun, A R Belch, S McKinnon, et al.Pharmacotherapy|March 12, 2003
Disposition of cefepime in the central nervous system of patients with external ventricular drainsDenise H Rhoney, Vincent H Tam, Dennis Parker, et al.Infection Control and Hospital Epidemiology|September 29, 2006
Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureusSusan L Davis, Michael J Rybak, Muhammad Amjad, et al.Managed Care Interface|February 22, 2007
The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspectivePeggy S McKinnon, Chureen T Carter, Prafulla G Girase, et al.Addiction Biology|July 14, 2010
Repeated ethanol administration modifies the temporal structure of sucrose intake patterns in mice: effects associated with behavioral sensitizationRaúl Pastor, Helen M Kamens, Carrie S McKinnon, et al.Critical Care Medicine|May 29, 2003
Bioavailability of gatifloxacin by gastric tube administration with and without concomitant enteral feeding in critically ill patientsSalmaan Kanji, Peggy S McKinnon, Jeffrey F Barletta, et al.Plos One|June 16, 2012
Male choice in the stream-anadromous stickleback complexJeffrey S McKinnon, Nick Hamele, Nicole Frey, et al.Diagnostic Microbiology and Infectious Disease|January 21, 2006
Pharmacodynamic profiling of cefepime in plasma and cerebrospinal fluid of hospitalized patients with external ventriculostomiesThomas P Lodise, Denise H Rhoney, Vincent H Tam, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 24, 2007
Prospective validation of an algorithm to identify hospitalized diabetic patients using administrative dataPeggy S McKinnon, Richard M Reichley, Laura A Noirot, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1997
Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patientsP S McKinnon, J A Paladino, M L Grayson, et al.Pageof 10